Adenovirus RID complex enhances degradation of internalized tumour necrosis factor receptor 1 without affecting its rate of endocytosis

References

1. Benedict C. A., Norris P. S., Prigozy T. I. & 7 other authors 2001; Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J Biol Chem 276:3270–3278 [CrossRef]
   [Google Scholar]
2. Carlin C. R., Tollefson A. E., Brady H. A., Hoffman B. L., Wold W. S. M. 1989; Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus. Cell 57:135–144 [CrossRef]
   [Google Scholar]
3. Chin Y. R., Horwitz M. S. 2005; Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RID α / β complex. J Virol 79:13606–13617 [CrossRef]
   [Google Scholar]
4. Crooks D., Kil S. J., McCaffery J. M., Carlin C. 2000; E3-13.7 integral membrane proteins encoded by human adenoviruses alter epidermal growth factor receptor trafficking by interacting directly with receptors in early endosomes. Mol Biol Cell 11:3559–3572 [CrossRef]
   [Google Scholar]
5. Delgado-Lopez F., Horwitz M. S. 2006; Adenovirus RID αβ complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression. J Virol 80:6378–6386 [CrossRef]
   [Google Scholar]
6. Efrat S., Fejer G., Brownlee M., Horwitz M. S. 1995; Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc Natl Acad Sci U S A 92:6947–6951 [CrossRef]
   [Google Scholar]
7. Efrat S., Serreze D., Svetlanov A., Post C. M., Johnson E. A., Herold K., Horwitz M. S. 2001; Adenovirus early region 3 (E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes 50:980–984 [CrossRef]
   [Google Scholar]
8. Elsing A., Burgert H.-G. 1998; The adenovirus E3/10.4K–14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc Natl Acad Sci U S A 95:10072–10077 [CrossRef]
   [Google Scholar]
9. Fessler S. P., Chin Y. R., Horwitz M. S. 2004a; Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1. J Virol 78:13113–13121 [CrossRef]
   [Google Scholar]
10. Fessler S. P., Delgado-Lopez F., Horwitz M. S. 2004b; Mechanisms of E3 modulation of immune and inflammatory responses. Curr Top Microbiol Immunol 273:113–135
    [Google Scholar]
11. Herbein G., O'Brien W. A. 2000; Tumor necrosis factor (TNF)- α and TNF receptors in viral pathogenesis. Proc Soc Exp Biol Med 223:241–257 [CrossRef]
    [Google Scholar]
12. Higuchi M., Aggarwal B. B. 1994; TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol 152:3550–3558
    [Google Scholar]
13. Hilgendorf A., Lindberg J., Ruzsics Z., Höning S., Elsing A., Löfqvist M., Engelmann H., Burgert H.-G. 2003; Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptor. J Biol Chem 278:51872–51884 [CrossRef]
    [Google Scholar]
14. Hoffman P., Carlin C. 1994; Adenovirus E3 protein causes constitutively internalized epidermal growth factor receptors to accumulate in a prelysosomal compartment, resulting in enhanced degradation. Mol Cell Biol 14:3695–3706
    [Google Scholar]
15. Hoffman B. L., Ullrich A., Wold W. S. M., Carlin C. R. 1990; Retrovirus-mediated transfer of an adenovirus gene encoding an integral membrane protein is sufficient to down regulate the receptor for epidermal growth factor. Mol Cell Biol 10:5521–5524
    [Google Scholar]
16. Horwitz M. S. 2004; Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins. J Gene Med 6:S172–S183 [CrossRef]
    [Google Scholar]
17. Krajcsi P., Wold W. S. M. 1992; The adenovirus E3-14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine. Virology 187:492–498 [CrossRef]
    [Google Scholar]
18. Krajcsi P., Tollefson A. E., Wold W. S. M. 1992; The E3–14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O -glycosylated but not N -glycosylated. Virology 188:570–579 [CrossRef]
    [Google Scholar]
19. Lichtenstein D. L., Doronin K., Toth K., Kuppuswamy M., Wold W. S. M., Tollefson A. E. 2004; Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2. J Virol 78:12297–12307 [CrossRef]
    [Google Scholar]
20. Mayor S., Presley J. F., Maxfield F. R. 1993; Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J Cell Biol 121:1257–1269 [CrossRef]
    [Google Scholar]
21. Pierce M. A., Chapman H. D., Post C. M., Svetlanov A., Efrat S., Horwitz M., Serreze D. V. 2003; Adenovirus early region 3 antiapoptotic 10.4K, 14.5K, and 14.7K genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes 52:1119–1127 [CrossRef]
    [Google Scholar]
22. Porteu F., Hieblot C. 1994; Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J Biol Chem 269:2834–2840
    [Google Scholar]
23. Shisler J., Yang C., Walter B., Ware C. F., Gooding L. R. 1997; The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J Virol 71:8299–8306
    [Google Scholar]
24. Tollefson A. E., Krajcsi P., Pursley M. H., Gooding L. R., Wold W. S. M. 1990; A 14,500 MW protein is coded by region E3 of group C human adenoviruses. Virology 175:19–29 [CrossRef]
    [Google Scholar]
25. Tollefson A. E., Stewart A. R., Yei S., Saha S. K., Wold W. S. M. 1991; The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J Virol 65:3095–3105
    [Google Scholar]
26. Tollefson A. E., Hermiston T. W., Lichtenstein D. L. 7 other authors 1998; Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392:726–730 [CrossRef]
    [Google Scholar]
27. Tollefson A. E., Toth K., Doronin K., Kuppuswamy M., Doronina O. A., Lichtenstein D. L., Hermiston T. W., Smith C. A., Wold W. S. M. 2001; Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J Virol 75:8875–8887 [CrossRef]
    [Google Scholar]
28. von Herrath M. G., Efrat S., Oldstone M. B. A., Horwitz M. S. 1997; Expression of adenoviral E3 transgenes in β cells prevents autoimmune diabetes. Proc Natl Acad Sci U S A 94:9808–9813 [CrossRef]
    [Google Scholar]
29. Yoshie O., Tada K., Ishida N. 1986; Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors. J Biochem (Tokyo) 100:531–541
    [Google Scholar]